- Vivint Solar Inc VSLR shares climbed 17.2 percent to $5.10. Goldman Sachs upgraded Vivint Solar from Neutral to Buy.
- Nantkwest Inc NK shares surged 8.3 percent to $7.67.
- Lipocine Inc LPCN shares gained 6.7 percent to $4.29 as the company disclosed that LPCN 1021 met its primary endpoint.
- Invivo Therapeutics Holdings Corp NVIV shares climbed 5.5 percent to $2.53 as the company reported new patient enrollment into INSPIRE study at Allegheny General Hospital.
- Fossil Group Inc FOSL shares gained 4.8 percent to $9.66. Buckingham upgraded Fossil Group from Underperform to Neutral.
- Lennar Corporation LEN shares rose 4.7 percent to $55.20 after the company reported stronger-than-expected results for its second quarter.
- Bellicum Pharmaceuticals Inc BLCM shares rose 4.5 percent to $13.48 after surging 13.86 percent on Monday.
- PAREXEL International Corporation PRXL shares gained 4.1 percent to $87.32 after WSJ reported that Pamplona Capital Management is near a deal to acquire the company for $88.10 per share.
- Clovis Oncology Inc CLVS shares rose 4 percent to $91.42. Janney Capital upgraded Clovis Oncology from Neutral to Buy.
- Marvell Technology Group Ltd. MRVL gained 2.5 percent to $17.86. Pacific Crest upgraded Marvell Technology from Sector Weight to Overweight.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in